Massachusetts Financial Services Co. MA bought a new position in Phibro Animal Health Corp (NASDAQ:PAHC) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 30,048 shares of the company’s stock, valued at approximately $1,290,000. Massachusetts Financial Services Co. MA owned about 0.07% of Phibro Animal Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. BlackRock Inc. boosted its position in shares of Phibro Animal Health by 7.7% in the second quarter. BlackRock Inc. now owns 3,304,441 shares of the company’s stock worth $152,169,000 after acquiring an additional 235,932 shares during the last quarter. Renaissance Technologies LLC boosted its position in shares of Phibro Animal Health by 18.2% in the second quarter. Renaissance Technologies LLC now owns 634,500 shares of the company’s stock worth $29,219,000 after acquiring an additional 97,700 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Phibro Animal Health by 4.1% in the second quarter. Dimensional Fund Advisors LP now owns 502,525 shares of the company’s stock worth $23,141,000 after acquiring an additional 19,807 shares during the last quarter. Segall Bryant & Hamill LLC acquired a new stake in shares of Phibro Animal Health in the second quarter worth approximately $21,724,000. Finally, Northern Trust Corp boosted its position in shares of Phibro Animal Health by 10.2% in the second quarter. Northern Trust Corp now owns 408,290 shares of the company’s stock worth $18,802,000 after acquiring an additional 37,946 shares during the last quarter. 47.95% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts recently issued reports on PAHC shares. Zacks Investment Research raised shares of Phibro Animal Health from a “sell” rating to a “buy” rating and set a $53.00 target price on the stock in a research report on Thursday, August 30th. BidaskClub raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, August 8th. Finally, Morgan Stanley raised their target price on shares of Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a research report on Wednesday, August 29th. Four research analysts have rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $43.20.

Shares of PAHC stock opened at $37.10 on Friday. The company has a market cap of $1.56 billion, a price-to-earnings ratio of 21.32, a price-to-earnings-growth ratio of 3.34 and a beta of 0.82. The company has a debt-to-equity ratio of 1.62, a quick ratio of 1.66 and a current ratio of 3.26. Phibro Animal Health Corp has a fifty-two week low of $32.05 and a fifty-two week high of $54.62.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Tuesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.03). The business had revenue of $200.20 million for the quarter, compared to analyst estimates of $203.99 million. Phibro Animal Health had a net margin of 7.89% and a return on equity of 38.91%. The company’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the firm earned $0.38 earnings per share. As a group, equities research analysts anticipate that Phibro Animal Health Corp will post 1.7 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.29%. This is a boost from Phibro Animal Health’s previous quarterly dividend of $0.10. The ex-dividend date is Tuesday, November 27th. Phibro Animal Health’s payout ratio is 22.99%.

In other Phibro Animal Health news, CEO Jack Bendheim sold 10,000 shares of Phibro Animal Health stock in a transaction that occurred on Monday, August 13th. The shares were sold at an average price of $50.03, for a total transaction of $500,300.00. Following the transaction, the chief executive officer now directly owns 60,000 shares of the company’s stock, valued at $3,001,800. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Daniel M. Bendheim sold 2,500 shares of Phibro Animal Health stock in a transaction that occurred on Wednesday, September 12th. The shares were sold at an average price of $44.30, for a total transaction of $110,750.00. Following the transaction, the vice president now directly owns 2,500 shares in the company, valued at $110,750. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 143,020 shares of company stock worth $6,967,571. 50.29% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “Massachusetts Financial Services Co. MA Buys Shares of 30,048 Phibro Animal Health Corp (PAHC)” was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://www.dailypolitical.com/2018/11/10/massachusetts-financial-services-co-ma-buys-shares-of-30048-phibro-animal-health-corp-pahc.html.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Recommended Story: Leveraged Buyout (LBO) Explained

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.